ARWR Annual Total Long Term Liabilities
$845.57 M
+$472.64 M+126.73%
30 September 2024
Summary:
As of January 23, 2025, ARWR annual total long term liabilities is $845.57 million, with the most recent change of +$472.64 million (+126.73%) on September 30, 2024. During the last 3 years, it has risen by +$690.78 million (+446.27%). ARWR annual total long term liabilities is now at all-time high.ARWR Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARWR Quarterly Long Term Liabilities
$845.57 M
+$397.50 M+88.71%
30 September 2024
Summary:
As of January 23, 2025, ARWR quarterly total long term liabilities is $845.57 million, with the most recent change of +$397.50 million (+88.71%) on September 30, 2024. Over the past year, it has increased by +$451.00 million (+114.30%). ARWR quarterly long term liabilities is now at all-time high.ARWR Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARWR Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +126.7% | +114.3% |
| 3 y3 years | +446.3% | +446.3% |
| 5 y5 years | +9576.4% | +446.3% |
ARWR Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +527.5% | at high | +651.9% |
| 5 y | 5-year | at high | +9576.4% | at high | +5863.7% |
| alltime | all time | at high | at high |
Arrowhead Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | $845.57 M(+126.7%) | $845.57 M(+88.7%) |
| June 2024 | - | $448.07 M(+13.6%) |
| Mar 2024 | - | $394.57 M(+1.5%) |
| Dec 2023 | - | $388.85 M(+4.3%) |
| Sept 2023 | $372.93 M(+176.8%) | $372.93 M(+8.5%) |
| June 2023 | - | $343.64 M(+1.4%) |
| Mar 2023 | - | $339.05 M(-9.1%) |
| Dec 2022 | - | $373.11 M(+176.9%) |
| Sept 2022 | $134.75 M(-12.9%) | $134.75 M(-9.8%) |
| June 2022 | - | $149.39 M(+32.9%) |
| Mar 2022 | - | $112.45 M(-12.8%) |
| Dec 2021 | - | $128.95 M(-16.7%) |
| Sept 2021 | $154.79 M(+672.3%) | $154.79 M(+50.9%) |
| June 2021 | - | $102.60 M(-28.8%) |
| Mar 2021 | - | $144.06 M(+631.8%) |
| Dec 2020 | - | $19.68 M(-1.8%) |
| Sept 2020 | $20.04 M(+129.4%) | $20.04 M(-1.6%) |
| June 2020 | - | $20.36 M(+43.6%) |
| Mar 2020 | - | $14.18 M(-1.4%) |
| Dec 2019 | - | $14.38 M(+64.5%) |
| Sept 2019 | $8.74 M(+118.2%) | $8.74 M(-63.7%) |
| June 2019 | - | $24.07 M(-23.6%) |
| Mar 2019 | - | $31.49 M(-9.6%) |
| Dec 2018 | - | $34.84 M(+770.0%) |
| Sept 2018 | $4.00 M(-10.1%) | $4.00 M(-0.3%) |
| June 2018 | - | $4.02 M(-3.4%) |
| Mar 2018 | - | $4.16 M(-3.4%) |
| Dec 2017 | - | $4.30 M(-3.3%) |
| Sept 2017 | $4.45 M(-40.7%) | $4.45 M(-14.7%) |
| June 2017 | - | $5.22 M(-12.8%) |
| Mar 2017 | - | $5.98 M(-40.5%) |
| Dec 2016 | - | $10.05 M(+33.9%) |
| Sept 2016 | $7.51 M(+11.3%) | $7.51 M(-33.4%) |
| June 2016 | - | $11.27 M(+70.1%) |
| Mar 2016 | - | $6.62 M(-0.9%) |
| Dec 2015 | - | $6.68 M(-0.9%) |
| Sept 2015 | $6.75 M(+35.3%) | $6.75 M(+37.3%) |
| June 2015 | - | $4.91 M(-1.2%) |
| Mar 2015 | - | $4.97 M(+0.9%) |
| Dec 2014 | - | $4.93 M(-1.1%) |
| Sept 2014 | $4.98 M(+73.7%) | $4.98 M(+94.3%) |
| June 2014 | - | $2.56 M(-2.1%) |
| Mar 2014 | - | $2.62 M(-5.2%) |
| Dec 2013 | - | $2.76 M(-3.7%) |
| Sept 2013 | $2.87 M(+20.0%) | $2.87 M(+90.7%) |
| June 2013 | - | $1.50 M(+0.7%) |
| Mar 2013 | - | $1.49 M(-3.5%) |
| Dec 2012 | - | $1.55 M(-35.2%) |
| Sept 2012 | $2.39 M | $2.39 M(+7.5%) |
| June 2012 | - | $2.22 M(+4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $2.14 M(-5.1%) |
| Dec 2011 | - | $2.25 M(+203.5%) |
| Sept 2011 | $742.40 K(>+9900.0%) | $742.40 K(+32.4%) |
| June 2011 | - | $560.90 K(+7.9%) |
| Mar 2011 | - | $519.70 K(>+9900.0%) |
| Dec 2010 | - | $0.00(0.0%) |
| Sept 2010 | $0.00(-100.0%) | $0.00(0.0%) |
| June 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | - | $0.00(-100.0%) |
| Sept 2009 | $500.00 K(-59.2%) | $500.00 K(-53.5%) |
| June 2009 | - | $1.07 M(-79.8%) |
| Mar 2009 | - | $5.31 M(-3.9%) |
| Dec 2008 | - | $5.53 M(+350.9%) |
| Sept 2008 | $1.23 M(+145.3%) | $1.23 M(+145.3%) |
| June 2008 | - | $500.00 K(0.0%) |
| Mar 2008 | - | $500.00 K(0.0%) |
| Dec 2007 | - | $500.00 K(0.0%) |
| Sept 2007 | $500.00 K(>+9900.0%) | $500.00 K(>+9900.0%) |
| June 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | - | $0.00(0.0%) |
| Sept 2006 | $0.00(0.0%) | $0.00(0.0%) |
| June 2006 | - | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) |
| Dec 2005 | - | $0.00(0.0%) |
| Sept 2005 | $0.00(0.0%) | $0.00(0.0%) |
| June 2005 | - | $0.00(0.0%) |
| Mar 2005 | - | $0.00(0.0%) |
| Dec 2004 | - | $0.00(0.0%) |
| Sept 2004 | $0.00(-100.0%) | $0.00(0.0%) |
| June 2004 | - | $0.00(-100.0%) |
| June 2003 | - | $27.50 K(0.0%) |
| Mar 2003 | - | $27.50 K(+5.8%) |
| Dec 2002 | - | $26.00 K(-5.5%) |
| Sept 2002 | $27.50 K(-16.7%) | $27.50 K(-5.2%) |
| June 2002 | - | $29.00 K(-4.9%) |
| Mar 2002 | - | $30.50 K(-4.7%) |
| Dec 2001 | - | $32.00 K(-3.0%) |
| Sept 2001 | $33.00 K(-15.4%) | $33.00 K(-4.3%) |
| June 2001 | - | $34.50 K(-4.2%) |
| Mar 2001 | - | $36.00 K(-4.0%) |
| Dec 2000 | - | $37.50 K(-3.8%) |
| Sept 2000 | $39.00 K(-9.3%) | $39.00 K(-3.7%) |
| June 2000 | - | $40.50 K(+3.8%) |
| Mar 2000 | - | $39.00 K(-1.3%) |
| Dec 1999 | - | $39.50 K |
| Sept 1999 | $43.00 K(-4.4%) | - |
| Sept 1998 | $45.00 K(>+9900.0%) | - |
| Sept 1997 | $0.00 | - |
FAQ
- What is Arrowhead Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Arrowhead Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of ARWR is $845.57 M
What is the all time high annual total long term liabilities for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual total long term liabilities is $845.57 M
What is Arrowhead Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, ARWR annual total long term liabilities has changed by +$472.64 M (+126.73%)
What is Arrowhead Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of ARWR is $845.57 M
What is the all time high quarterly long term liabilities for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly total long term liabilities is $845.57 M
What is Arrowhead Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, ARWR quarterly total long term liabilities has changed by +$451.00 M (+114.30%)